Book a demo

Company intelligence

Prostate Cancer Institute of America (PCIA)

We exclusively treat prostate cancer using the most advanced techniques in prostate brachytherapy.

Hospitals and Health Care
3 employees
Founded 2023
1 public signals

About Prostate Cancer Institute of America (PCIA)

Prostate Cancer Institute of America was founded in 2022 by Dr. Ajay Bhatnagar and is the only practice in the United States exclusively dedicated to providing LDR-Brachytherapy services. Low Dose Rate Brachytherapy (also known as radioactive seed therapy) is an evidence-based radiation cancer treatment that delivers high cure rates, minimal side effects and has the best rates of erectile function preservation. We use the latest technology, including Theraseed Pd-103 radioactive sources, and we use real-time, AI assisted treatment planning during brachytherapy cases which results in the most precise and accurate treatment. At PCIA, we take a team-based approach to treating prostate cancer patients and work with urologists to deliver outstanding patient care and effective results. Learn more about this approximate hour-long and highly effective procedure.

Verified activity

Signals from Prostate Cancer Institute of America (PCIA)

1 published signal

Find the companies already in motion.

Customize signals around your market, buyers, competitors, and investment thesis.

© 2026 SeedOpsCompany intelligence.

SeedOps.